Playback speed
10 seconds
Prefusion-Stabilized SARS-CoV-2 Spikes: Will High-Yield Production of a Stabilized Prefusion Spike Protein Accelerate the Development of Vaccines and Serological Diagnostics for SARS-CoV-2?
By
Columbia University's Zuckerman Institute
FEATURING
Jason Mclellan
By
Columbia University's Zuckerman Institute
FEATURING
Jason Mclellan
82 views
September 23, 2020
Login to view comments.
Click here to Login